Scimar

We are unleashing a new paradigm in type 2 diabetes prevention and treatment. Based in Manitoba, Canada, SciMar is driven by a passion to change the course of human health as type 2 diabetes exacts a frightful toll on communities around the world. Rates of type 2 diabetes and the conditions that lead to it—especially obesity—are skyrocketing everywhere. The current paradigms for preventing and treating type 2 diabetes are not working. Through rigorous science, deep passion, and significant investment, SciMar has made important progress in the lab; has moved through the early stages of regulatory approval in Canada and the United States; and has protected key elements of its intellectual property and product pipeline with patents in 10 countries. Clinical trials are moving forward; a change in global health and well-being is on the horizon.